Susan Hasty, Publisher
Table of Contents . . . February 22nd, 1999
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Cancer Weekly | Other Publications
Cancer Gene Therapy - Oncolytic Adenovirus Enhances Suicide Gene Therapy
Cancer Immunotherapy - Administration Route Affects Efficacy of IL-12 Therapy
Cancer Immunotherapy - Early Results of INF-(alpha) for Renal Carcinoma are Mixed
Cancer Immunotherapy - Monoclonal Antibodies Studied as Immune Effectors
Cancer Radioimmunotherapy - CEA mAb Enhances Tumor Uptake in Radioimmunotherapy Protocol
Cancer Therapies (Endostatin) - Anti-Cancer Drug Enters New Phase
Drug Development - Potent Angiogenesis Inhibitor Licensed
Immunomodulation - Tamoxifen - More than Just Chemotherapy
Industry News (Joint Venture) - Research Agreement Modified for Angiostatin Protein
Anticancer Agents - Dox Enzymatically Assembled on MAb Specific for CEA
Burkitt's Lymphoma - No Evidence of Selection for Certain EBV Strains
Genomics (HBV) - MutatedxProteins Involved in Cancer Link
Genomics (HCV) - bcl-2 Appears Related to Liver Cancer
Growth Factors - Fusion Toxins Target VEGF Receptors
Growth Factors - VEGF May Have Smaller Role Than flt-1 in Angiogenesis
Oncology - HCV Linked to non-Hodgkin's Lymphoma Risk
Alternative Therapies - Patients Desire Active Role in Treatment
Breast Cancer (Clinical Trials) - Fabricated/Falsified Data Reported for Three Patients on Studies
Breast Cancer (Risk Factors) - Microscopic Change May Double Risk for Some Women
Cervical Cancer (Screening) - HPV Test, Education, and Early Detection Recommended
Conference Announcement - 30th Annual SGO Gathering Offers Medical Research Findings
Disease Associations (HIV/HPV) - Protease Inhibitor Use Associated with Rise in Oral Warts Incidence
Lung Cancer - Researcher Finds Culprit in Cancer Metastasis
Lung Cancer (Animal Models) - Positive Oral Efficacy Results in Mouse Model for Cancer Announced
Pain Management - "PENS" Cancer, Herpes Pain Therapy Research Studies Published
Pharmacokinetics - FTIs Control Cell Growth by Altering RHO Proteins
Risk Factors - Organ Transplant Drug May Cause Cancer
Cancer Immunotherapy - "Generation of Tumor-Specific Cytotoxic T Lymphocytes against Cervical Cancer Cell Lines by In Vitro Stimulation with a Synthetic Human Papilloma Virus Type 16 E7 Epitope."
Cancer Immunomodulators - "Plant Interferons, A New Group of Immunomodulators against Viral Infections and Malignancies."
Cancer Immunotherapy - "Immunogene Therapy Using Recombinant Adenoviral Vectors to Express Melanoma Antigens in the B16 Melanoma Model."
Disease Associations - "Phenotypical and Histological Patterns of Lymphomas in HIV Patients Before and After HAART."
Disease Associations - "The Epstein-Barr Virus BALF1 Gene Encodes a Viral Bcl-2 Homlog That Heterodimerizes with Bax and Bak."
Tumor Angiogenesis - "Role of E-Selectin in the Tumor Microenvironment."
Antisense Therapy - "Antisense Oligodeoxynucleotides Downregulated c-sis nRNA Expression To Inhibit Proliferation of Vascular Smooth Muscle Cells."
Bacterial Anticancer Agents - "Lipid A Mutant Salmonella With Suppressed Virulence and TNF alpha Induction Retain Tumor-Targeting in vivo."
Cancer Gene Therapy - "Simultaneous Protection of G156A Methylguanine DNA Methyltransferase Gene-Transduced Hematopoietic Progenitors and Sensitization of Tumor Cells Using O-6-benzylguanine and Temozolomide."
Cancer Immunotherapy - "Prolonged Upregulation of the Expression of HLA Class I Antigens and Costimulatory Molecules on Melanoma Cells Treated With 5-aza-2 '-deoxycytidine (5-AZA-CdR). DO
Colorectal Cancer - "Human Leukocyte Antigens as Genetic Markers in Colorectal Carcinoma."
Drug Resistance - "Combined Cytotoxic Effects of Tumor Necrosis Factor-alpha With Various Cytotoxic Agents in Tumor Cell Lines That Are Drug Resistant Due to Mutated p53."
Head and Neck Cancer - "Impairment of T-Cell Activation in Head and Neck Cancer in situ and in vitro - Strategies for an Immune Restoration."
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.